We are live on
!
Find out more
JSC
Jackson Square Capital Portfolio holdings
AUM
$477M
1-Year Est. Return
78.87%
This Fund
S&P 500
This Quarter
Est. Return
-1.76%
1 Year Est. Return
+78.87%
3 Year Est. Return
+244.4%
5 Year Est. Return
+377.15%
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$31.7M
(-13%)
Cap. Flow
-$25.1M
Cap. Flow
% of AUM
-12.26%
Top 10 Holdings %
Top 10 Hldgs %
37.46%
Holding
155
New
17
Increased
33
Reduced
54
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$4.43M |
| 2 |
GlobalFoundries
GFS
|
+$2.27M |
| 3 |
Analog Devices
ADI
|
+$1.46M |
| 4 |
Target
TGT
|
+$1.34M |
| 5 |
Stryker
SYK
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$5.55M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
+$2.66M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.45M |
| 4 |
Apple
AAPL
|
+$2.37M |
| 5 |
Halliburton
HAL
|
+$2.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.36% |
| 2 | Healthcare | 21.13% |
| 3 | Energy | 9.75% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Financials | 7.45% |
Similar funds
FAM
BHWA
MVP
ACM
TCM
PCMC
CMI
BF
Jackson Square Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Jackson Square Capital held 155 positions worth $205M, down 13% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Jackson Square Capital withdrew a net $25.1M in Q3 2022, closing 33 positions and reducing 54 holdings. Its most notable exit was Sierra Oncology, Inc. Common Stock, an estimated $5.55M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Jackson Square Capital opened a new position in Synopsys worth $4M.
- Jackson Square Capital's largest Q3 2022 buy was Synopsys: 13,078 shares worth $4M.
- Jackson Square Capital added most to Analog Devices in Q3 2022, an estimated $1.46M increase.
- Jackson Square Capital's biggest Q3 2022 reduction was Marathon Oil Corporation, cutting an estimated $2.66M.
- Jackson Square Capital fully exited Sierra Oncology, Inc. Common Stock in Q3 2022, selling an estimated $5.55M.
- Jackson Square Capital's ten largest holdings make up 37% of its $205M portfolio in Q3 2022.
- Jackson Square Capital opened 17 new positions and closed 33 in Q3 2022.
- Jackson Square Capital's portfolio value fell 13% quarter-over-quarter to $205M.
Based on Jackson Square Capital's 13F filing for Q3 2022, filed 13 Oct 2022.